Zengmian Yiliu formula suppresses cell cycle in immune-rich ovarian cancer patient-derived organoids
{{output}}
Background: Ovarian cancer, often diagnosed at advanced stages, has a 5-year survival rate below 50%, indicating a critical need for innovative treatments. The Zengmian Yiliu (ZMYL) formula, a Traditional Chinese Medicine (TCM) p... ...
